Published in Rheumatology (Oxford) on June 29, 2011
Vitamin D in inflammatory diseases. Front Physiol (2014) 1.10
Vitamin d deficiency in patients with systemic lupus erythematosus. Oman Med J (2013) 0.94
Environmental influences on systemic lupus erythematosus expression. Rheum Dis Clin North Am (2014) 0.92
Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep (2012) 0.90
Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med (2014) 0.86
Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci (2012) 0.86
Understanding lupus nephritis: diagnosis, management, and treatment options. Int J Womens Health (2012) 0.85
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review. PLoS One (2013) 0.85
Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.84
Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol (2013) 0.83
Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol (2012) 0.83
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med (2015) 0.82
Do low vitamin D levels cause problems of waste removal in patients with SLE? Rheumatology (Oxford) (2011) 0.76
Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus. Front Immunol (2015) 0.76
Bone disease in newly diagnosed lupus nephritis patients. PLoS One (2014) 0.75
The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial. J Res Med Sci (2017) 0.75
Effects of 1,25(OH)2 D3 and vitamin D receptor on peripheral CD4(+) /CD8(+) double-positive T lymphocytes in a mouse model of systemic lupus erythematosus. J Cell Mol Med (2017) 0.75
Immunomodulators in SLE: Clinical evidence and immunologic actions. J Autoimmun (2016) 0.75
25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus. PLoS One (2015) 0.75
High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China. Am J Clin Exp Immunol (2016) 0.75
Vitamin D receptor gene BsmI polymorphisms in Egyptian children and adolescents with systemic lupus erythematosus: A case-control study. Medicine (Baltimore) (2016) 0.75
Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region. Rheumatol Int (2016) 0.75
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59
Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med (2007) 2.50
Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol (2004) 2.49
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol (2005) 1.90
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol (2005) 1.74
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol (2007) 1.63
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol (2012) 1.57
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res (2010) 1.49
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int (2005) 1.40
Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res (2002) 1.33
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis (2004) 1.31
Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer (2010) 1.28
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice? Clin J Am Soc Nephrol (2012) 1.25
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int (2009) 1.24
Optimizing ACE-inhibitor therapy for chronic kidney disease. N Engl J Med (2006) 1.18
Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18
Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis (2007) 1.18
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis (2006) 1.12
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol (2015) 1.09
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol (2009) 1.08
Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol (2011) 1.07
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol (2004) 1.05
Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum (2005) 1.05
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients. Nephron Clin Pract (2009) 1.05
Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis (2008) 1.02
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine (2002) 1.01
D-dimer level and the risk for thrombosis in systemic lupus erythematosus. Clin J Am Soc Nephrol (2008) 1.00
My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.00
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta (2010) 0.99
Induction of chemokine expression by adiponectin in vitro is isoform dependent. Transl Res (2009) 0.98
Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol (2006) 0.98
N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Physiol Renal Physiol (2013) 0.98
FcγRIIb on liver sinusoidal endothelium clears small immune complexes. J Immunol (2012) 0.98
Mycophenolate therapy of SLE membranous nephropathy. Kidney Int (2004) 0.97
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications. Clin J Am Soc Nephrol (2008) 0.97
Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int (2005) 0.97
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum (2006) 0.96
Rituximab or azathioprine maintenance in ANCA-associated vasculitis. N Engl J Med (2015) 0.95
Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. Kidney Int (2004) 0.95
Kidney complications of hematopoietic stem cell transplantation. Am J Kidney Dis (2013) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum (2008) 0.94
Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol (2003) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum (2008) 0.94
Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis (2010) 0.94
Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res (2012) 0.94
A quantitative proteomic workflow for characterization of frozen clinical biopsies: laser capture microdissection coupled with label-free mass spectrometry. J Proteomics (2012) 0.92
APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N Engl J Med (2007) 0.91
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol (2014) 0.91
A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model (2008) 0.91
Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol Reprod (2004) 0.91
Expression of the decay-accelerating factor (CD55) in renal transplants--a possible prediction marker of allograft survival. Transplantation (2009) 0.90
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option. Clin J Am Soc Nephrol (2009) 0.88
Can we personalize treatment for kidney diseases? Clin J Am Soc Nephrol (2009) 0.88